United States
US 12,702,698 B2
GLP-1 compositions and uses thereof
US 12,702,698 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: Novo Nordisk A/S. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Novo Nordisk A/S
- Inventors
- Eva Horn Moeller; Michael Duelund Soerensen; Joakim Lundqvist
- Publication date
- 2026-08-11
- Filing date
- 2023-07-26
- Document type
- B2 Granted patent
- Also written as
- US 12,702,698 B2 · US12702698 · 12702698
Abstract
The present invention relates to pharmaceutical compositions of the GLP-1 peptide semaglutide comprising no more than 0.01% (w/w) phenol, their preparation, kits comprising such compositions as well as uses thereof.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free